Literature DB >> 4367720

Proceedings: The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I-desamino-8-d-arginine vasopressin, angiotensin and oxytocin in man.

J D Cash, A M Gader, J da Costa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4367720

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  17 in total

1.  Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.

Authors:  S Lethagen; A S Harris; I M Nilsson
Journal:  Blut       Date:  1990-03

2.  Use of desmopressin in the treatment of hemophilia A: towards a golden jubilee.

Authors:  Pier Mannuccio Mannucci
Journal:  Haematologica       Date:  2018-03       Impact factor: 9.941

Review 3.  Desmopressin (DDAVP) and hemostasis.

Authors:  S Lethagen
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

4.  Differing coagulation profiles of patients with monoclonal gammopathy of undetermined significance and multiple myeloma.

Authors:  Maeve P Crowley; Maeve P Crowely; Shane Quinn; Eoin Coleman; Joseph A Eustace; Oonagh M Gilligan; Susan I O'Shea; Susan I O Shea
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

Review 5.  The use of vasopressin in the treatment of upper gastrointestinal haemorrhage.

Authors:  D L Stump; T C Hardin
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

6.  A decreased and less sustained desmopressin response in hemophilia A carriers contributes to bleeding.

Authors:  Victoria Candy; Hilary Whitworth; Julie Grabell; Lisa Thibeault; Lori Harpell; Mackenzie Bowman; David Good; Wilma M Hopman; Robert F Sidonio; Paula D James
Journal:  Blood Adv       Date:  2018-10-23

7.  Evidence for intact V1-vasopressin receptors in congenital nephrogenic diabetes insipidus.

Authors:  N Knoers; P M Janssens; J Goertz; L A Monnens
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

Review 8.  Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment.

Authors:  N Knoers; L A Monnens
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

Review 9.  Prophylaxis of bleeding episodes in patients with von Willebrand's disease.

Authors:  Augusto B Federici
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443

10.  Pharmacokinetics and haematological effects of desmopressin.

Authors:  M Köhler; A Harris
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.